Real-time data for cancer therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Researchers discover that aspartate is a limiter of cell proliferation.
A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery.
Nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.
An MIT faculty member since 1995, Hammond succeeds Klavs Jensen as ChemE department head.
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
New center will incorporate research on the study of aging in the Department of Biology, Picower Institute for Learning and Memory, and David H. Koch Institute for Integrative Cancer Research.
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
Cancer biologist and Koch Institute director recognized with MIT faculty’s top honor.
Optimal size and shape allow implantable devices to last longer in the body.
Device can measure the distribution of tiny particles as they flow through a microfluidic channel.
Bhatia is recognized for her work in tissue engineering, disease detection, and advocacy for women in STEM.